BioHealth News

Bio: House passes bill restoring full R&D expensing

Bio: House passes bill restoring full R&D expensing

Read More
Maxim Biomedical, Inc. Secures Second NIH RADx Tech High Performance Award for Continued Development of At-Home FiarFly™ Reader and COVID-19 & Flu A/B Rapid Test

Maxim Biomedical, Inc. Secures Second NIH RADx Tech High Performance Award for Continued Development of At-Home FiarFly™ Reader and COVID-19 & Flu A/B Rapid Test

Read More
U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials

U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials

Read More
BioBuzz: Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative

BioBuzz: Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative

Read More
Baltimore’s LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China

Baltimore’s LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China

Read More
GEN: Top 10 Biopharma Takeover Targets of 2024

GEN: Top 10 Biopharma Takeover Targets of 2024

Read More
Deadline Approaching: Apply to Be Part of the Maryland Delegation at BIO 2024

Deadline Approaching: Apply to Be Part of the Maryland Delegation at BIO 2024

Read More
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment

FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment

Read More
Infinity Bio Launches Next-Generation Antibody Profiling Platform Utilizing MIPSA Technology

Infinity Bio Launches Next-Generation Antibody Profiling Platform Utilizing MIPSA Technology

Read More
Revolo Biotherapeutics Receives Orphan Drug Designation from the U.S. FDA for its First-in-Class Peptide as a Potential Treatment for Eosinophilic Esophagitis

Revolo Biotherapeutics Receives Orphan Drug Designation from the U.S. FDA for its First-in-Class Peptide as a Potential Treatment for Eosinophilic Esophagitis

Read More
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers

MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers

Read More
Calling all MedTech innovators: Up to $100,000 in federal grants to be awarded

Calling all MedTech innovators: Up to $100,000 in federal grants to be awarded

Read More
The Daily Record: New Johns Hopkins institute aims to make Baltimore an AI hub

The Daily Record: New Johns Hopkins institute aims to make Baltimore an AI hub

Read More
PQE Group: 100+M€ In Revenues, Expansion In Emerging Markets and Business Lines

PQE Group: 100+M€ In Revenues, Expansion In Emerging Markets and Business Lines

Read More
First Patient Enrolled in Rockville’s Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial

First Patient Enrolled in Rockville’s Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial

Read More
View All Posts